Medications

Novartis generics unit Sandoz makes stock market debut

Swiss generic drugs group Sandoz began trading as an independent company in Zurich on Wednesday, in a stock market debut following a spin-off by parent company Novartis as it pivots toward new drug development.

Medications

Drugmakers agree to US govt price talks amid pushback

Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesday, a key element in President Joe Biden's push to lower health care costs ahead of the 2024 election.

Medications

Merck sues to challenge new US drug price program

Merck filed a lawsuit Tuesday challenging a new White House-backed program to limit drug prices, calling the initiative an unconstitutional "extortion" that will harm pharmaceutical innovation.

page 2 from 22